Trial intelligence / Profile preview

Preventive low-dose dexmedetomidine for postoperative sleep quality in elderly SICU patients

ChiCTR-TRC-12002567Phase 4Completed

Sponsor
Peking University First Hospital
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) and sleep disorder (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Sleep structure and cycle and Subjective sleep quality. Started Oct 2012; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)sleep disorder

Beyond the preview

Go deeper on ChiCTR-TRC-12002567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call